Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin's lymphoma.
Chin J Cancer
; 34(11): 522-30, 2015 Sep 14.
Article
in En
| MEDLINE
| ID: mdl-26370464
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Non-Hodgkin
/
Antineoplastic Combined Chemotherapy Protocols
/
Hematopoietic Stem Cell Mobilization
/
Rituximab
Type of study:
Etiology_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Chin J Cancer
Journal subject:
NEOPLASIAS
Year:
2015
Type:
Article